These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL. Ortega JJ; Ribera JM; Oriol A; Bastida P; González ME; Calvo C; Egurbide I; Hernández Rivas JM; Rivas C; Alcalá A; Besalduch J; Maciá J; Gardella S; Carnero M; Lite JM; Casanova F; Martinez M; Fontanillas M; Feliu E; San Miguel JF; Haematologica; 2001 Jun; 86(6):586-95. PubMed ID: 11418367 [TBL] [Abstract][Full Text] [Related]
7. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol. Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691 [TBL] [Abstract][Full Text] [Related]
16. Clinical features and treatment outcome of children with myeloid antigen coexpression in B-lineage acute lymphoblastic leukemia: a study of 151 Malaysian children. Ng SM; Ariffin WA; Lin HP; Chan LL; Chin YM J Trop Pediatr; 2000 Apr; 46(2):73-8. PubMed ID: 10822932 [TBL] [Abstract][Full Text] [Related]
17. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology. Ribera JM; Ortega JJ; Oriol A; Fontanillas M; Hernández-Rivas JM; Brunet S; García-Conde J; Maldonado J; Zuazu J; Gardella S; Besalduch J; León P; Macià J; Domingo-Albós A; Feliu E; San Miguel JF Haematologica; 1998 Mar; 83(3):222-30. PubMed ID: 9573676 [TBL] [Abstract][Full Text] [Related]
18. The prognostic impact of myeloid antigen expression in pediatric acute lymphoblastic leukemia patients. Unal S; Cetin M; Tuncer AM; Gümrük F; Yetgin S Turk J Pediatr; 2008; 50(6):533-6. PubMed ID: 19227415 [TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of CD13 identifies a subgroup of standard-risk adult acute lymphoblastic leukemia with inferior survival. Dalal BI; Al Mugairi A; Pi S; Lee SY; Khare NS; Pal J; Bryant A; Vakil AP; Lau S; Abou Mourad YR Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):239-44. PubMed ID: 24411984 [TBL] [Abstract][Full Text] [Related]
20. Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86. Ludwig WD; Harbott J; Bartram CR; Komischke B; Sperling C; Teichmann JV; Seibt-Jung H; Notter M; Odenwald E; Nehmer A Recent Results Cancer Res; 1993; 131():269-82. PubMed ID: 8210646 [No Abstract] [Full Text] [Related] [Next] [New Search]